These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17968318)

  • 21. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
    Zhang Y; Xiong Y
    Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of nucleolar versus non-nucleolar forms of human p14(ARF).
    Rodway H; Llanos S; Rowe J; Peters G
    Oncogene; 2004 Aug; 23(37):6186-92. PubMed ID: 15286709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
    Rizos H; Darmanian AP; Mann GJ; Kefford RF
    Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of p14ARF through subnuclear compartmentalization.
    Gjerset RA; Bandyopadhyay K
    Cell Cycle; 2006 Apr; 5(7):686-90. PubMed ID: 16627991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of the tumor suppressor ARF in oncogenesis].
    Pimkina IuS; Dorosevich AE
    Arkh Patol; 2009; 71(1):60-3. PubMed ID: 19514363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional link between the tumour suppressors ARF and p33ING1.
    González L; Freije JM; Cal S; López-Otín C; Serrano M; Palmero I
    Oncogene; 2006 Aug; 25(37):5173-9. PubMed ID: 16607280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
    Kuo ML; den Besten W; Thomas MC; Sherr CJ
    Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B23 and ARF: friends or foes?
    Lindström MS; Zhang Y
    Cell Biochem Biophys; 2006; 46(1):79-90. PubMed ID: 16943625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of p14ARF with Brca1 in cancer cell lines and primary breast cancer.
    He L; Fan C; Ning X; Feng X; Liu Y; Chen B; Tang D
    Cell Biol Int; 2008 Oct; 32(10):1302-9. PubMed ID: 18703154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
    Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
    Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.
    Wang J; He X; Luo Y; Yarbrough WG
    Biochem J; 2006 Jan; 393(Pt 2):489-501. PubMed ID: 16173922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma.
    Mascaux C; Bex F; Martin B; Burny A; Haller A; Paesmans M; Willard-Gallo K; Ninane V; Sculier JP
    Eur Respir J; 2008 Sep; 32(3):678-86. PubMed ID: 18480108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two wobble-splicing events affect ING4 protein subnuclear localization and degradation.
    Tsai KW; Tseng HC; Lin WC
    Exp Cell Res; 2008 Oct; 314(17):3130-41. PubMed ID: 18775696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.